These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25368970)

  • 21. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer.
    Boddy JL; Pike DJ; Al-Hayek S; Shaida N; Malone PR
    Prostate Cancer Prostatic Dis; 2005; 8(4):349-52. PubMed ID: 16010283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of free prostate-specific antigen measurement in prostate-specific antigen screening for prostate cancer.
    Johnson L
    Clin Prostate Cancer; 2002 Dec; 1(3):142-4. PubMed ID: 15046688
    [No Abstract]   [Full Text] [Related]  

  • 23. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
    Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
    BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies.
    Gershman B; Zietman AL; Feldman AS; McDougal WS
    Urol Oncol; 2013 Oct; 31(7):1093-7. PubMed ID: 22305626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer.
    Fowler JE; Bigler SA; Miles D; Yalkut DA
    J Urol; 2000 Mar; 163(3):813-8. PubMed ID: 10687983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The influence of prostate volume on the diagnostic parameters related to PSA and clinicopathological features of prostate cancer].
    Kimura G; Kimata R; Saito Y; Yoshida K; Nishimura T
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():479-85. PubMed ID: 12599623
    [No Abstract]   [Full Text] [Related]  

  • 27. Percentage of free prostate-specific antigen: implications in modern extended scheme prostate biopsy.
    Lee BH; Moussa AS; Li J; Fareed K; Jones JS
    Urology; 2011 Apr; 77(4):899-903. PubMed ID: 21146865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining prostate cancer risk before prostate biopsy.
    Pal RP; Maitra NU; Mellon JK; Khan MA
    Urol Oncol; 2013 Nov; 31(8):1408-18. PubMed ID: 22795499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study.
    Stewart GD; Van Neste L; Delvenne P; Delrée P; Delga A; McNeill SA; O'Donnell M; Clark J; Van Criekinge W; Bigley J; Harrison DJ
    J Urol; 2013 Mar; 189(3):1110-6. PubMed ID: 22999998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer detection rate at repeat saturation biopsy: PCPT risk calculator versus PCA3 score versus case-finding protocol.
    Pepe P; Aragona F
    Can J Urol; 2013 Feb; 20(1):6620-4. PubMed ID: 23433132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of PSA and its indices in determining the need for repeat prostate biopsies.
    Ukimura O; Durrani O; Babaian RJ
    Urology; 1997 Jul; 50(1):66-72. PubMed ID: 9218021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Change in serum prostate specific antigen values in men who had no evidence of prostate cancer on initial biopsy].
    Miyamoto S; Jimbo H; Totsuka Y; Mashimo T; Umeyama T; Uehara H; Shinozaki T
    Hinyokika Kiyo; 1995 Oct; 41(10):767-70. PubMed ID: 8533671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific antigen (PSA) should drive doing prostate biopsies.
    Loeb S; Catalona WJ
    Urol Oncol; 2012; 30(1):1-2. PubMed ID: 21458316
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostate specific antigen adjusted for transition zone epithelial volume: the powerful predictor for the detection of prostate cancer on repeat biopsy.
    Ohigashi T; Kanao K; Kikuchi E; Nakagawa K; Nakashima J; Marumo K; Murai M
    J Urol; 2005 May; 173(5):1541-5. PubMed ID: 15821482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy.
    Moreira DM; Gerber L; Thomas JA; Bañez LL; McKeever MG; Freedland SJ
    Int J Urol; 2012 Aug; 19(8):741-7. PubMed ID: 22487442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship of the positive rate of TRUS guided prostatic biopsies with routine diagnostic findings in detecting prostate cancer].
    Ma H; Wan B
    Zhonghua Nan Ke Xue; 2013 Jan; 19(1):40-3. PubMed ID: 23469660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the prostate cancer antigen 3 (PCA3) test for the diagnosis of prostate cancer in the era of opportunistic prostate-specific antigen screening.
    Ficarra V; Novara G; Zattoni F
    Eur Urol; 2010 Oct; 58(4):482-4; discussion 484-5. PubMed ID: 20685032
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis].
    van der Kwast TH; Hoedemaeker RF; Schröder FH
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):972-6. PubMed ID: 15903037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
    J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.